ArticleBriefings in bioinformatics2025
ETNet: an interpretable transformer framework for enhancer-enhancer interaction prediction with cross-context transferability.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Enhancer-enhancer interactions (EEIs) are critical regulatory components in transcriptional networks but remain computationally challenging to predict. While enhancer-promoter interactions have been extensively studied, EEIs remain comparatively underexplored. We developed ETNet (Enhancer-enhancer Interaction Explainable Transformer Network), a deep learning architecture integrating convolutional neural networks with Transformer modules to predict EEIs from DNA sequences. Evaluation across three cell lines (GM12878, K562, MCF-7) demonstrated superior performance compared to existing methods including EnContact, with statistical significance confirmed through DeLong tests across six cell lines. Rigorous validation through cross-validation and enhancer-level data partitioning confirmed robust generalization. ETNet exhibited effective cross-cell type transfer learning and showed transferability to enhancer-promoter interaction tasks, providing exploratory evidence for shared chromatin interaction principles. Feature attribution analysis recovered cell-type-specific regulatory motifs consistent with known transcription factors and revealed computational evidence for super-additive cooperative mechanisms, with cooperativity negatively correlating with sequence similarity-patterns representing hypothesis-generating observations requiring experimental validation. Proof-of-concept analysis demonstrated how single-nucleotide polymorphisms in JAK-STAT pathway genes may influence predicted interactions through motif alterations. ETNet advances computational approaches for studying enhancer interactions and provides a framework combining predictive capability with exploratory interpretability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.